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ABSTRACT The effects of 100 ,tM ryanodine on the L-type calcium channel were studied using the pacth-clamp techniquein isolated guinea pig ventricular myocytes. The inactivation kinetics of the calcium current were slowed down in the presence
of ryanodine in agreement with the blockade of the release of calcium from the sarcoplasmic reticulum by the drug. The I-V
and steady-state inactivation curves of the calcium current were shifted to negative values by ryanodine. A similar shift was
observed in the activation and inactivation curves of the intramembrane charge movement associated with the calcium
channel. Due to this shift, ryanodine slightly reduced the maximal amount of displaced charge although it did not modify the
transition from the inactivated to the activated state (i.e., charge movement repriming). This result is in notable contrast with
that obtained in skeletal muscle, where it has been found that ryanodine interferes with charge movement repriming. These
results provide additional evidence of the postulated differences between the architecture of the excitation-contraction
coupling system in cardiac and skeletal muscle.
INTRODUCTION
Excitation-contraction coupling (ECC) in cardiac and skeletal
muscle occurs by different mechanisms, although the molec-
ular components of the coupling machinery are basically the
same. In skeletal muscle fibers, dihydropyridine receptors
(DHPRs) localized in the transverse tubule membrane operate
as voltage sensors and generate the intramembrane charge
movement, providing the gating signal for primary calcium
release from the ryanodine receptors (RYRs) in the sarcoplas-
mic reticulum (SR) (Rios and Pizarro, 1991). The molecular
architecture of the transverse tubules (T)-SR junction in skel-
etal muscle strongly suggests a direct interaction between the
two receptors (Block et al., 1988). Such interaction has re-
cently been demonstrated in vitro (Marty et al., 1994) and in
reconstituted systems (Lu et al., 1994), but an in vivo demon-
stration at the cellular level is still lacking.
In cardiac muscle, the different spatial relationship and
stoichiometry of DHPRs and RYRs determines a different
type of coupling (Bers and Stiffel, 1993). Here, DHPRs
localized in the sarcolemma function as voltage-dependent
calcium channels and allow calcium entry into the cells (see
references in McDonald et al., 1994). This calcium triggers
additional calcium release from the SR via SR calcium
channels, which have been identified as RYRs (Fabiato,
1985; Meissner, 1986). Thus, in heart muscle, intramem-
brane charge movement does not participate in ECC as a
voltage sensor (Nabauer et al., 1989) but instead it is
thought to provide the voltage-dependent gating of sar-
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colemmal sodium and calcium channels (Bean and Rios,
1989; Hadley and Lederer, 1989, 1991a; Shirokov et al.
1992).
Ryanodine is a natural alkaloid that binds with high
specificity and affinity to the calcium release channels of
SR of both skeletal and cardiac muscle cells (Meissner,
1986; Meissner and El Hashem, 1992). It has been shown in
normally polarized skeletal muscle fibers that ryanodine
does not affect the basic properties of intramembrane charge
movement (Fryer et al., 1989; Garcia et al., 1991). How-
ever, it does interfere with the repriming of charge move-
ment after prolonged membrane depolarization (Gonzalez
and Caputo, 1994, 1995). It has been suggested that ryano-
dine binding to its receptor locks the voltage sensor in its
inactivated state and does not allow the transition from the
inactivated to the available state when the fibers are repo-
larized (Gonzalez and Caputo, 1995). This would imply a
retrograde action of ryanodine effective from the intracel-
lular calcium release channel of the SR to the DHPR in the
sarcolemma, consistent with the mechanical hypothesis of
ECC (Rios and Pizarro 1991; Rios et al., 1993). However,
ryanodine could act directly on the DHPR in its depolarized
state without involving the RYR.
In cardiac muscle the organization of the T-SR junction is
different and no mechanical interaction is expected to occur
between DHPRs and RYRs. Thus, the effect of ryanodine
on the repriming of charge movement in cardiac cells con-
stitutes a crucial test for the retrograde hypothesis of ryano-
dine action on skeletal muscle. In this work we have mea-
sured the effect of ryanodine at a concentration that would
be maximally effective in skeletal muscle (Gonzalez and
Caputo, 1995) on the charge movement associated with the
gating of calcium channels in cardiac myocytes. Although
ryanodine slightly diminishes charge movement in normally
polarized cells, it does not affect the transition of charge
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Cardiac myocytes were isolated from guinea pig ventricles using the
procedure described by Le Guennec et al. (1990). Isolated cells were
placed in a 1-ml experimental chamber on the stage of an inverted micro-
scope (TMS, Nikon). They were continuously perfused at the rate of 1
ml/min with a Tyrode solution (in mM): 140 NaCl, 5.4 KCI, 1 MgCl2, 1.8
CaCl2, 11 glucose, 0.33 NaH2PO4, 10 Hepes; pH adjusted to 7.3 with
NaOH.
Experimental solutions
Cells were internally dialyzed with a pipette solution (mM): 110 CsCl, 30
tetraethylammonium chloride (TEA-Cl), 5 Mg-ATP, 10 EGTA, 10 Hepes;
pH adjusted to 7.3 (CsOH). Calcium current was measured with an extra-
cellular solution containing (mM): 140 TEA-Cl, 6 CsCl, 1 MgCl2, 1.8
CaCl2, 11 glucose, 10 Hepes; pH adjusted to 7.3 with TEA-OH. Intramem-
brane charge movements were measured with an extracellular solution
containing (mM): 140 TEA-Cl, 1 MgCl2, 1.0 CaC12, 2 CdCl2, 0.1 GdCl3,
10-3 tetrodotoxin, 11 glucose, 10 Hepes; pH adjusted to 7.3 with TEA-OH.
Gadolinium was employed as calcium channel blocker (Lacampagne et al.,
1994). External solutions were applied to the cells by superfusion with
microcapillaries. Ryanodine (Sigma Chemical Co., LaVerpilliere, France)
was added to both external solutions at the final concentration of 100 JIM
from a stock solution. Experiments were performed at room temperature
(22-25°C).
Experimental procedures
Voltage clamp experiments were performed in the whole-cell configuration
of the patch-clamp technique (Hamill et al., 1981), with an Axopatch 200A
(Axon Instruments, Foster City, CA). The pipettes, with a resistance from
2 to 3 Mfl, were pulled with a PB7 puller (Narishige, Tokyo, Japan). To
eliminate the pipette fast capacitance transient, the pipettes were coated
with dental wax. In all experiments the pipette and cell capacitance were
compensated. Small cells were selected for the experiments and the mean
cell capacitance was 108 ± 6.4 pF. Except for experiments in which
calcium current ('Ca), current-voltage, and steady-state inactivation were
measured, the series resistance was compensated by 70-80%. The data
were filtered by an 8-pole low-pass Bessel filter at 5 kHz, or 1 kHz when
series resistance was compensated. In addition, a P/5 subtraction protocol
was used to remove any residual leak and capacitance currents. The cell
capacitance was measured by integration of the capacitance transient
elicited by a 10-mV hyperpolarization pulse from a holding potential of
-80 mV (in every case the value measured was similar to that given by the
amplifier after compensation). ICa was measured as the difference between
the peak current and the current recorded at the end of the depolarization.
Gating currents were analyzed by integrating the first 25 ms of the
depolarization (QON) after defining the steady-state current level as that
recorded during the last 5 ms of the pulse. QOFF was measured by
integrating the current recorded during the first 25 ms of repolarization and
subtracting the baseline of the steady-state current recorded at the end of
this period and is expressed as the absolute value. Voltage-dependent
relationships of gating currents were fitted by the following Boltzmann
equation:
Qca = QCamax/{1 + exp [(V -VCa)/k]} (1)
where Qcamax is the maximal charge, k the slope factor and Vca the voltage
for the half-maximal activation.
Statistical analysis was done by comparison of the fitting parameters
obtained for each cell (see Table 1) using an unpaired t-test (p<0.05 was
considered significant). The results are expressed as the mean ± SE.
RESULTS
It is known that ryanodine at 10 ,uM does not affect calcium
currents in skeletal muscle (Garcia et al. 1991). In cardiac
muscle it has been reported that ryanodine causes small
changes in the inactivation properties of ICa. Thus, this
effect is possibly an indirect one, caused by calcium re-
leased from the SR due to the action of ryanodine (Boyett et
al., 1988; Balke and Wier, 1991). A first series of experi-
ments was carried out to test the effect of ryanodine at high
concentration, 100 ,iM, on ICa. This concentration keeps the
RYR at the closed configuration (Lindsay et al., 1994) and
was shown by Gonzalez and Caputo (1995) to significantly
decrease the repriming of intramembrane charge movement
in skeletal muscle. At this concentration, ryanodine caused
a 10-mV shift in the I-V relationship as it is shown in Fig.
1 A. The steady-state inactivation curve (Fig. 1 B) was also
shifted and the degree of inactivation increased over the
whole range of explored voltages. Similar results were
obtained in three cells. Cohen and Lederer (1988) found an
opposite shift but only in the inactivation curve. Ryanodine
also affected the inactivation kinetics of ICa. As shown in
Fig. 2 A, the time course of inactivation was slowed down.
This result was obtained in three other cells. A similar effect
has been obtained at lower concentrations of ryanodine
(Mitchell et al., 1984; Boyett et al., 1988; Cohen and Le-
derer, 1988; Balke and Wier, 1991) and was attributed to
ryanodine inhibiting SR calcium release.
TABLE I Effect of 100 1,M ryanodine on calcium channel charge movement
Control (n = 8) Ryanodine (100 ,uM; n = 6) Repriming (100 ,M ryanodine; n = 5)
Qcamax VCa k Qcamax Vca k Qcamax VCa k
(nC/,F) (mV) (mV) (nC/LF) (mV) (mV) (nC/,LF) (mV) (mV)
QON 8.68 ± 0.49 -13.74 ± 1.74 10.32 ± 0.77 7.99 ± 0.52 -18.16 ± 2.01 9.88 ± 1.02 6.15 ± 0.71 -17.61 ± 4.53 9.99 ± 1.21
QOFF 7.46 ± 0.5 -10.81 ± 1.3 12.14 ± 0.74 6.17 ± 0.76 -16.95 ± 2.36 10.12 ± 1.02 5.13 ± 1.05 -22.15 ± 2.16 7.32 ± 0.73
Cell data were individually fitted to Eq. 1 and values of the fitting parameters of QON and QOFF are given as mean ± SE. Statistical analysis compared
data from control and ryanodine and from ryanodine and repriming ryanodine. There was no significant difference in the second comparison, indicating
that ryanodine is without effect on the repriming of calcium channel charge movement. From the first comparison there was a significant decrease of Qc.ama
and a significant shift of the activation curves induced by ryanodine.
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FIGURE 1 I-V and steady-state inactivation curves of ICa were obtained
with a double-pulse voltage-clamp protocol. A 450-ms depolarizing test
pulse from a holding potential of -80 to 0 mV was preceded by 450-ms
depolarizing prepulse from -80 to 80 mV in 10-mV increments. In both
curves the currents are normalized to the maximal value of 'Ca (U, control;
0, 100 ,uM ryanodine). (A) 5 min after application of ryanodine the I-V
curve is shifted by -10 mV to the left. (B) Under the same conditions we
can see the loss of the potentiation observed in control between -80 and
-40 mV, a 10-mV shift to the left and an increase in the inactivation
between 20 and 80 mV.
Because of the different voltage sensitivity of the sodium
and calcium channel gating currents, it is possible to isolate
the latter by inactivating the former with conditioning de-
polarizations (Hadley and Lederer, 1989, 1991a; Bean and
Rios, 1989; Shirokov et al. 1992). To measure intramem-
brane charge movement associated with the gating of cal-
cium channels we used the pulse protocol shown in the
upper part of Fig. 3 A. In this figure the records on the left
were obtained under normal conditions, whereas those on
the right were obtained after 5 min of exposure to 100 IuM
ryanodine. It appears that under these conditions ryanodine
has little effect on the intramembrane charge movement,
causing only a small decrease in Qc... Fig. 3 B and Table
1 summarize the results obtained from several cells. The
symbols in the graphs of Fig. 3 B represent, respectively, the
QON and QOFF mean values obtained from the time integrals
of the nonlinear currents plotted against the membrane
potential. The continuous lines were calculated using a
two-state Boltzmann equation as described in Materials and
Methods. The mean on and off values obtained in these cells
FIGURE 2 (A) Normalized ICa elicited by a 100-ms depolarization pulse
from a holding of -80 to 0 mV every 10 s, sampled at 10 kHz. Ryanodine
slows down the time course of inactivation of the current. (B) Normalized
QON elicited by a 20-mV depolarization pulse according to the protocol
described in Fig. 3. Ryanodine was without effect upon the kinetics of the
gating currents. (-, control; 0, 5 min after application of 100 ,uM ryano-
dine).
were 7.46 and 8.78 nC/,uF, respectively, in agreement with
previously published values (Bean and Rios, 1989; Shi-
rokov et al., 1992). Ryanodine reduced the maximal charge
Qc,ax by -10% and shifted the activation curve toward
negative values by 5 mV, whereas the slope factor (k) was
unchanged. These effects were not associated with changes
in the kinetics of the gating currents (n = 4), as illustrated
in Fig. 2 B.
Fig. 3 C shows the availability curves of the on charge
movement, obtained in seven cells using a double-pulse
protocol. The holding potential was -100 mV and under
these conditions a double Boltzmann fitting showed the
existence of two components of charge. In control condi-
tions, the more negative component represents -27% of the
total charge and is probably associated with the inactivation
of the sodium channel, which is completely inactivated at
-60 mV (Bean and Rios, 1989). The more positive com-
ponent corresponds to the inactivation of the calcium chan-
nels, which begins at around ---50 mV and is maximal at
20 mV. After application of ryanodine no significant
changes were observed either in the amount of sodium or
calcium charge or in the slope factors. However, a shift in
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FIGURE 3 Effect of ryanodine on the activation and inactivation of in-
tramembrane charge movement. (A) Protocol used to measure activation of
L-type calcium channel charge movement. The cells were maintained at a
holding potential of -100 mV, depolarized to -50 mV for 100 ms to
inactivate sodium channel charge movement, depolarized for 30 ms to test
pulse voltages (TIP) from -60 to +25 mV, and repolarized to -50 mV for 30
ms. The signals were sampled at 16.5 kHz; the protocol was repeated every 6
s. To diminish high freqency noise the records shown are the averages of three
runs. The left column illustrates gating currents recorded under control con-
ditions and the right column shows the currents after a 5-min exposure to 100
eM ryanodine. (B) Effect of ryanodine on the voltage dependence of charge
movement (top, QON; bottom, QOFF).*, mean ± SE of the charge density in
control (n = 8); *, after a 5-min exposure to ryanodine (n = 6). The lines were
obtained by fitting all individual data to Eq. 1. Ryanodine induced a small
decrease of gating current, as shown by the following fitting parameters. In the
upper graph (QON). QCarriax = 8.86 ± 0.34, Vca = -13.62 ± 1.4, k = 10.94
± 1.02 in control and Qc..,, = 7.09 ± 0.38, Vc. = -17.55 ± 2.04, k =
10.53 ± 1.59 in ryanodine. In the lower graph (QOFF), Qcama = 7.85 ± 0.45,
Vca =-9.43 ± 2.17, k = 13.0 ± 1.35 in control and Qcaa,a = 6.58± 0.46,
Vca = -15.75 + 2.66, k = 11.0 ± 2.01 in ryanodine. (C) Inactivation of
charge movement obtained with the protocol shown in the inset. Holding
potential, -100 mV; prepulse (PP) duration, 500 ms; interpulse, 5 ms; test
pulse, 30 ms at 20 mV; n = 7. ( ), control; ( -- -), 100pM
ryanodine. Values fitted to the equation Q = Qo + QN1/{1 + exp[(VNa -
V)/KNa]} + QcA{ + exp[(Vca - V)/Kca] }. Fitting parameters (mean ± SE):
Qo = 0.16, QNa = 0.27 ± 0.0, Qca = 0-57 ± 0.0, VNa = -88.8 ± 2.0, VCa
=
-27.0 2.1, KNa = 3.78 ± 1.8, and Kca = 10.8 ± 1.9 in control; Qo =
0.19, QNa 0.28 ± 0.0, Qca = 0.53 ± 0.0, VNa = 85.5 ± 3.5, Vc = 34.5
± 2.4, KNa = 5.97 ± 2.9, KCa = 7.56 ± 1.9 in ryanodine.
negative potentials was obtained, which was similar to the
shift observed in Fig. 1, A and B and Fig. 3 B. This suggests
that the 10% inhibition of Qc (Fig. 3 B and Table 1) is
the consequence of partial inactivation of the calcium chan-
nels at -50 mV in the presence of ryanodine.
In view of the finding that ryanodine significantly re-
duced charge movement repriming in skeletal muscle
(Gonzalez and Caputo, 1995) it was important to test
whether this was also the case for cardiac cells. To study
charge movement repriming, the pulse protocol illustrated
in Fig. 4 A was used. Repriming at the steady state was
studied using a repolarization interval (At) of more than 30
s after the inactivation depolarization of 2 min at 0 mV. The
degree of repriming was tested with a second depolarization
(TP) to different voltages. Fig. 4, A and B, and Table 1 show
that ryanodine has no significant effect on the steady-state
repriming of charge movement. We also explored the time
course of repriming in the absence and presence of ryano-
dine (Fig. 4 C). This time, we used a constant test pulse (TP
= 0 mV) and At was varied from 250 ms to 60 s. Fig. 4 Ca
shows the results expressed in charge density (nC/,F) and
confirms the lack of effect of ryanodine on the repriming
process. Fig. 4 Cb gives the normalized values and shows
the absence of effect of ryanodine on the kinetics of the time
course of repriming.
DISCUSSION
The main point of this study is that ryanodine does not
interfere with repriming of intramembrane charge move-
ment in cardiac myocytes. This contrasts with recent work
showing that ryanodine reduces repriming of intramem-
brane charge movement in skeletal muscle (Gonzalez and
Caputo, 1994, 1995). Thus, in skeletal muscle, ryanodine
binding to its receptor severely disrupts repriming of charge
movement whereas in cardiac muscle it does not. The re-
sults presented here weaken the possibility that ryanodine
might act directly on the DHPR molecule during the tran-
sition from the inactivated to the reprimed state. Taken
together the results reported here and those of Gonzalez and
Caputo (1995) support the mechanical coupling model pro-
posed for skeletal muscle (Chandler et al, 1976; Rios and
Pizarro, 1991; Gonzalez and Rios 1993; Rios et al., 1993).
This model is based on a protein-protein interaction be-
tween DHPRs and RYRs that is favored by the molecular
disposition and stoichiometry of the two macromolecules at
the level of the T-SR junction (Block et al., 1988; Bers and
Stiffel, 1993). This arrangement is not found in cardiac
muscle.
There are varying reports of the effect of ryanodine on the
function of sarcolemmal calcium channels in cardiac mus-
cle. It is generally thought that the effect is not direct but
mediated by calcium released from the SR. However, we
show that high concentrations of ryanodine induce some
changes in the voltage dependence of the calcium channel.
We have also found a small decrease in the maximal acti-
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FIGURE 4 Effect of ryanodine on charge movement repriming. (A) Protocol
used to measure the steady-state repriming of intramembmne charge movement. It
is similar to that described in Fig. 3, but to test repriming, before stimulation the
cells were maintained for 2 min at 0 mV to inactivate charge movement (sur-
rounded by dotted lines) then repolarized for at least 30 s (At) to -100 mV to
reprime the inhraembrane charge movement. Gating currents were recorded after
a 5-min exposure to 100 pM ryanodine before (left panel) and after (right panel
repriming. (B) Effect ofryanodine on the voltage dependence ofcharge movement
(top, QON, bottom QOFF) before and after repiming. 0, mean ± SE of the charge
density after a 5-min exposure to ryanodine (n = 6); 0, after repriming (n = 5).
The lines were obtained by fitting all individual data to Eq. 1. Ryanodine is without
significant effect on gating current repiming as shown by the following fitting
pammeters: upper graph (QON) before rpriming, Qca. = 7-09 ± 0.38, Vc =
-17.55 ± 2.04, k = 10.53 ± 1.59; after repriming, Qc,.. = 6.42 ± 0.66, Vca
=-18.58 ± 3.85, k = 10.63 ± 2.92; and lower graph (-QOFF) before repriming,
Qca,, = 6.58 ± 0.46, Vc. = -15.75 ± 2.66, k = 11.0 2.01; after repriming,
Qca,,. = 6.23 ± 0.86, Vc = -16.9 ± 5.25, k = 11.48 3.79. (C) Time course
of repriming studied with the same protocol as in A. Test pulse was fixed at 0 mV
and At was varied from 250 ms to 60 s (n = 5, for all At). , control; 0, ryanodine.
(a) Represents values as charge density. (b) Values normalized to the 60-s value.
vation of charge movement (Qca,x) that could be due to a
decreased release of SR calcium (but see Hadley and Le-
derer, 1991b; Shirokov et al., 1993) but is more probably
related to the recorded shift in the voltage dependence of the
calcium channel. We have no explanation for this shift, but
it can be interpreted as a consequence of a local increase in
calcium concentration in the vicinity of the calcium chan-
nels. Our results are in contrast to those of Cohen and
Lederer (1988) as they obtained a shift in the opposite
direction. This shift cannot be interpreted by a local change
in calcium concentration as it was obtained only for the
inactivation curve.
It is known that the cytoplasmic loop region between
transmembrane repeats II and III of the DHPR is a deter-
mining factor for skeletal-muscle-type ECC (Tanabe et al.,
1988, 1990; Garcia et al., 1994). It has been shown that this
loop region may activate SR calcium release channels (Lu et
al., 1994). Interestingly, loop regions of cardiac and skeletal
muscle were both effective in the activation of skeletal
muscle release channels but not of cardiac release channels
(Lu et al., 1994). These results are compatible with the
finding that modification of the RYR by ryanodine differ-
entially affects its interaction with the DHPR during
repriming in cardiac and skeletal muscle.
Changes of the membrane potential cause transitions
between different physical states in the sensor molecules
(Bezanilla et al., 1982). In skeletal muscle it is possible that
during these transitions the interactions between specific
regions of the DHPR and RYR are favored, causing con-
formational changes in the RYR that lead to the opening of
the SR calcium release channels. It has been proposed that,
after steady membrane potential changes, the gating mole-
cules occupy a different set of physical states that still allow
transitions across the membrane but in a different potential
range (Shirokov et al., 1992). In skeletal muscle, ryanodine
binding to the RYR might cause the DHPR to remain locked
in the conformation corresponding to the inactivated state,
thus impeding repriming. This effect would be favored by
the molecular arrangement of DHPRs and RYRs in the
T-SR junction, which provides the structural basis for ECC
in skeletal muscle. In contrast to the model proposed by
Cohen and Lederer (1988), our results indicate that for
cardiac muscle functional interactions between RYRs and
DHPRs do not occur and intramembrane charge movement
and its repriming are not affected by ryanodine. The calci-
um-mediated inactivation of DHPRs in cardiac muscle
would be the equivalent of the negative feedback postulated
above for skeletal muscle. In this sense one can suggest that
the retrograde effect of RYRs on the repriming of DHPRs
could be a mechanism that participates in the tonus modu-
lation of skeletal muscle in case of strong or maintained
depolarizations.
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